This is the on line version of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up in this article to get it delivered every Thursday to their inbox.
Bankruptcies, restructurings, scientific trial setbacks, and slipping inventory costs: It’s been a disconcerting 7 days in Biotech Land. Luckily for us, this e-newsletter has arrived like a heat hug. I want to listen to from you! Send me electronic mail at [email protected].
Weed for excess weight decline
Skye Bioscience was the moment a battling, money-starved penny inventory. Now, the organization is developing a treatment method for being overweight that was uncovered via investigation into cannabis, and that may well be additive to the GLP-1 blockbusters. Predictably, buyers have taken observe.
Keep on to STAT+ to study the entire story…